Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Influenza

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

November 2018
1. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
   Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
   Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
   PubMed     Text format     Abstract available
   
   
   October 2018
2. GOLDHILL DH, Te Velthuis AJW, Fletcher RA, Langat P, et al
   The mechanism of resistance to favipiravir in influenza.
   Proc Natl Acad Sci U S A. 2018 Oct 23. pii: 1811345115.
   PubMed     Text format     Abstract available
   
   
   September 2018
3. BENTON DJ, Nans A, Calder LJ, Turner J, et al
   Influenza hemagglutinin membrane anchor.
   Proc Natl Acad Sci U S A. 2018 Sep 17. pii: 1810927115.
   PubMed     Text format     Abstract available
   
   
   
4. SJAASTAD LE, Fay EJ, Fiege JK, Macchietto MG, et al
   Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo.
   Proc Natl Acad Sci U S A. 2018 Sep 4. pii: 1807516115.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. MADSEN JJ, Grime JMA, Rossman JS, Voth GA, et al
   Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding.
   Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1805443115.
   PubMed     Text format     Abstract available
   
   
   
6. LEE JM, Huddleston J, Doud MB, Hooper KA, et al
   Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants.
   Proc Natl Acad Sci U S A. 2018 Aug 13. pii: 1806133115.
   PubMed     Text format     Abstract available
   
   
   July 2018
7. DENG L, Chang TZ, Wang Y, Li S, et al
   Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
   Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
   PubMed     Text format     Abstract available
   
   
   
8. GUALDONI GA, Mayer KA, Kapsch AM, Kreuzberg K, et al
   Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication.
   Proc Natl Acad Sci U S A. 2018;115:E7158-E7165.
   PubMed     Text format     Abstract available
   
   
   
9. LIN X, Noel JK, Wang Q, Ma J, et al
   Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill.
   Proc Natl Acad Sci U S A. 2018 Jul 16. pii: 1805442115.
   PubMed     Text format     Abstract available
   
   
   June 2018
10. UEKI H, Wang IH, Fukuyama S, Katsura H, et al
    In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs.
    Proc Natl Acad Sci U S A. 2018 Jun 25. pii: 1806265115.
    PubMed     Text format     Abstract available
    
    
    
11. ZHOU J, Li C, Sachs N, Chiu MC, et al
    Differentiated human airway organoids to assess infectivity of emerging influenza virus.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1806308115.
    PubMed     Text format     Abstract available
    
    
    April 2018
12. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Text format     Abstract available
    
    
    
13. KADAM RU, Wilson IA
    A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Proc Natl Acad Sci U S A. 2018 Apr 2. pii: 1801999115.
    PubMed     Text format     Abstract available
    
    
    February 2018
14. PEI S, Kandula S, Yang W, Shaman J, et al
    Forecasting the spatial transmission of influenza in the United States.
    Proc Natl Acad Sci U S A. 2018 Feb 26. pii: 1708856115.
    PubMed     Text format     Abstract available
    
    
    
15. ZHOU J, Wei J, Choy KT, Sia SF, et al
    Defining the sizes of airborne particles that mediate influenza transmission in ferrets.
    Proc Natl Acad Sci U S A. 2018 Feb 20. pii: 1716771115.
    PubMed     Text format     Abstract available
    
    
    January 2018
16. YAN J, Grantham M, Pantelic J, Bueno de Mesquita PJ, et al
    Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.
    Proc Natl Acad Sci U S A. 2018 Jan 18. pii: 1716561115.
    PubMed     Text format     Abstract available
    
    
    
17. MENACHERY VD, Schafer A, Burnum-Johnson KE, Mitchell HD, et al
    MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1706928115.
    PubMed     Text format     Abstract available
    
    
    December 2017
18. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Text format     Abstract available
    
    
    November 2017
19. ELKINS MR, Williams JK, Gelenter MD, Dai P, et al
    Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMR.
    Proc Natl Acad Sci U S A. 2017 Nov 20. pii: 201715127.
    PubMed     Text format     Abstract available
    
    
    
20. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Text format     Abstract available
    
    
    September 2017
21. ZANIN M, Wong SS, Barman S, Kaewborisuth C, et al
    Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potential.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201713974.
    PubMed     Text format     Abstract available
    
    
    
22. MAAMARY J, Wang TT, Tan GS, Palese P, et al
    Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201707950.
    PubMed     Text format     Abstract available
    
    
    August 2017
23. THOMASTON JL, Woldeyes RA, Nakane T, Yamashita A, et al
    XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conduction.
    Proc Natl Acad Sci U S A. 2017 Aug 23. pii: 201705624.
    PubMed     Text format     Abstract available
    
    
    July 2017
24. NIKOLAIDIS NM, Noel JG, Pitstick LB, Gardner JC, et al
    Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.
    Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201621172.
    PubMed     Text format     Abstract available
    
    
    
25. ASGARI S, Schlapbach LJ, Anchisi S, Hammer C, et al
    Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.
    Proc Natl Acad Sci U S A. 2017 Jul 17. pii: 201704259.
    PubMed     Text format     Abstract available
    
    
    
26. BLACKMORE S, Hernandez J, Juda M, Ryder E, et al
    Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2017 Jul 10. pii: 201620415.
    PubMed     Text format     Abstract available
    
    
    May 2017
27. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Text format     Abstract available
    
    
    April 2017
28. XIE J, Sok D, Wu NC, Zheng T, et al
    Immunochemical engineering of cell surfaces to generate virus resistance.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201702764.
    PubMed     Text format     Abstract available
    
    
    
29. SHANKS GD, Brundage JF
    Variable mortality during the 1918 influenza pandemic in Chicago.
    Proc Natl Acad Sci U S A. 2017 Apr 6. pii: 201701344.
    PubMed     Text format    
    
    
    March 2017
30. BASKERVILLE EB, Cobey S
    Does influenza drive absolute humidity?
    Proc Natl Acad Sci U S A. 2017 Mar 15. pii: 201700369.
    PubMed     Text format    
    
    
    February 2017
31. KREMENTSOV DN, Case LK, Dienz O, Raza A, et al
    Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201620889.
    PubMed     Text format     Abstract available
    
    
    December 2016
32. WU CY, Lin CW, Tsai TI, Lee CD, et al
    Influenza A surface glycosylation and vaccine design.
    Proc Natl Acad Sci U S A. 2016 Dec 27. pii: 201617174.
    PubMed     Text format     Abstract available
    
    
    
33. KADAM RU, Wilson IA
    Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.
    Proc Natl Acad Sci U S A. 2016 Dec 21. pii: 201617020.
    PubMed     Text format     Abstract available
    
    
    
34. PING J, Lopes TJ, Neumann G, Kawaoka Y, et al
    Development of high-yield influenza B virus vaccine viruses.
    Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201616530.
    PubMed     Text format     Abstract available
    
    
    November 2016
35. CHOWELL G, Viboud C
    Pandemic influenza and socioeconomic disparities: Lessons from 1918 Chicago.
    Proc Natl Acad Sci U S A. 2016;113:13557-13559.
    PubMed     Text format    
    
    
    
36. GRANTZ KH, Rane MS, Salje H, Glass GE, et al
    Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918.
    Proc Natl Acad Sci U S A. 2016 Nov 21. pii: 201612838.
    PubMed     Text format     Abstract available
    
    
    
37. BJORNSTAD ON, Viboud C
    Timing and periodicity of influenza epidemics.
    Proc Natl Acad Sci U S A. 2016 Nov 3. pii: 201616052.
    PubMed     Text format    
    
    
    October 2016
38. DEYLE ER, Maher MC, Hernandez RD, Basu S, et al
    Global environmental drivers of influenza.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201607747.
    PubMed     Text format     Abstract available
    
    
    
39. YAMIN D, Jones FK, DeVincenzo JP, Gertler S, et al
    Vaccination strategies against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201522597.
    PubMed     Text format     Abstract available
    
    
    
40. RAMEY AM, Spackman E, Kim-Torchetti M, DeLiberto TJ, et al
    Weak support for disappearance and restricted emergence/persistence of highly pathogenic influenza A in North American waterfowl.
    Proc Natl Acad Sci U S A. 2016;113:E6551-E6552.
    PubMed     Text format    
    
    
    
41. LIANG R, Swanson JM, Madsen JJ, Hong M, et al
    Acid activation mechanism of the influenza A M2 proton channel.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615471.
    PubMed     Text format     Abstract available
    
    
    
42. MOREIRA EA, Locher S, Kolesnikova L, Bolte H, et al
    Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201608821.
    PubMed     Text format     Abstract available
    
    
    
43. HE W, Tan GS, Mullarkey CE, Lee AJ, et al
    Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    Proc Natl Acad Sci U S A. 2016 Oct 3. pii: 201609316.
    PubMed     Text format     Abstract available
    
    
    September 2016
44. LEON PE, He W, Mullarkey CE, Bailey MJ, et al
    Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
    Proc Natl Acad Sci U S A. 2016 Sep 19. pii: 201613225.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: